Current Strategies for Prevention and Treatment of Postoperative Endophthalmitis
Purpose of review
We review the prevention and treatment of postoperative endophthalmitis.
Postoperative endophthalmitis is rare but has potentially blinding consequences. There is no consensus on prevention, but there are a few controlled studies with methods of decreasing the infection rate, such as use of povidone iodine and intracameral antibiotics. There remains only one randomized controlled study (Endophthalmitis Vitrectomy Study or EVS) on the treatment of postoperative endophthalmitis, but there are retrospective studies which examine the timing and various methods of vitrectomy and intravitreal antibiotics.
The application of povidone iodine remains a proven method of preventing endophthalmitis, but evidence suggests that intracameral antibiotics further minimize this risk. Further research is needed to define the efficacy of intravitreal antibiotics at the time of cataract surgery. There are many questions regarding treatment, including performance of vitrectomy for eyes with visual acuities better than light perception, smaller vitrectomy port sizes, and intravitreal antibiotics and/or oral steroids.
KeywordsEndophthalmitis Postoperative endophthalmitis Intracameral antibiotics
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States. Natl Health Stat Rep. 2006;2009(11):1–25.Google Scholar
- 12.Haripriya A, Baam ZR, Chang DF. Endophthalmitis prophylaxis for cataract surgery. Asia Pac J Ophthalmol (Phila). 2017;6(4):324–9.Google Scholar
- 16.Ophthalmologists, T.R.C.O. Cataract surgery guidelines. 2010.Google Scholar
- 21.Li B, Nentwich MM, Hoffmann LE, Haritoglou C, Kook D, Kampik A, et al. Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg. 2013;39(7):994–1001.PubMedGoogle Scholar
- 48.ASCRS, ASCRS Clinical Survey 2016. Eyeworld Supplements. 2016.Google Scholar
- 56.Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88.Google Scholar
- 58.Daien V, Papinaud L, Gillies MC, Domerg C, Nagot N, Lacombe S, et al. Effectiveness and safety of an Intracameral injection of cefuroxime for the prevention of endophthalmitis after cataract surgery with or without perioperative capsular rupture. JAMA Ophthalmol. 2016;134(7):810–6.PubMedGoogle Scholar
- 70.• Witkin AJ, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124(5):583–95. This case series identified 36 eyes of 23 patients diagnosed with hemorrhagic occlusive retinal vasculitis (HORV) following routine use of intracameral vancomycin during cataract surgery. These eyes had delayed-onset vision loss with devastating consequences: 61% had final visual acuity of 20/200 or worse. Because of this study, the Americian Society of Cataract and Refractive Surgeons (ASCRS) recommended against the use of intracameral vancomycin during cataract surgery. PubMedGoogle Scholar
- 72.•• Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology. 2017;124(6):768–75. This retrospective study of over 600,000 patients demonstrated that intracameral moxifloxacin reduced the postoperative endophthalmitis rate by 3.5-fold. Moxifloxacin is of particular interest because it does not have to be compounded by a pharmacy and, thus, precludes dilution errors. PubMedGoogle Scholar
- 80.Conrady CD, Feistmann JA, Roller AB, Boldt HC, Shakoor A. Hemorrhagic vasculitis and retinopathy heralding as an early sign of bacterial endophthalmitis after intravitreal injection. Retin Cases Brief Rep. 2017:1.Google Scholar
- 81.Conrady CD, Hanson KE, Mehra S, Carey A, Larochelle M, Shakoor A. The first case of Trypanosoma cruzi-associated retinitis in an immunocompromised host diagnosed by pan-organism PCR. Clin Infect Dis. 2018;(In press).Google Scholar
- 86.Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995;113(12):1479–96.Google Scholar
- 94.Escariao P, Commodaro AG, Arantes T, CMMB C, MFA D, Brandt CT. Analysis of cytokines in presumed acute infectious endophthalmitis following cataract extraction. J Clin Exp Ophthalmol. 2014;5:335.Google Scholar
- 95.• Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E, et al. Post-injection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab and aflibercept. Am J Ophthalmol. 2016. This large retrospective study helped to define rates and visual outcomes of post-injection endophthalmitis that were similar amongst all anti-VEGF agents with rates between 0.035 and 0.039%.;165:88–93.PubMedGoogle Scholar
- 97.Ravindran RD, Venkatesh R, Chang DF, Sengupta S, Gyatsho J, Talwar B. Incidence of post-cataract endophthalmitis at Aravind Eye Hospital: outcomes of more than 42,000 consecutive cases using standardized sterilization and prophylaxis protocols. J Cataract Refract Surg. 2009;35(4):629–36.PubMedGoogle Scholar
- 101.•• Shalaby A, Di Simplicio Cherubini S, Lockwood A, Newsom R. Postoperative endophthalmitis: incidence, causes and comparison between medical and surgical treatment in a United Kingdom region in the last 10 years. Acta Ophthalmol. 2015;93(S255) This paper was a retrospective case review of 60 patients with endophthalmitis from various causes in which the patients with count fingers vision or worse vision that received vitrectomy had significantly better visual outcomes than those that only received intravitreal antibiotics. This raises questions as to whether the presenting visual acuity guidelines should be altered to guide clinicians on when to perform a vitrectomy.Google Scholar
- 104.Waheed S, Ritterband DC, Greenfield DS, Liebmann JM, Seedor JA, Ritch R. New patterns of infecting organisms in late bleb-related endophthalmitis: a ten year review. Eye (Lond). 1998;12(Pt 6):910–5.Google Scholar
- 121.Bronner S, Jehl F, Peter JD, Ploy MC, Renault C, Arvis P, et al. Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrob Agents Chemother. 2003;47(5):1621–9.PubMedPubMedCentralGoogle Scholar
- 131.Yagci R, et al. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Eye (Lond). 2007;21(7):990–4.Google Scholar
- 140.Jacobs DJ, et al. Intravitreal dexamethasone in the management of delayed-onset bleb-associated endophthalmitis. Int J Inflamm. 2012;2012:503912.Google Scholar